Stereotaxis, Inc. (STXS)
NYSEAMERICAN: STXS · IEX Real-Time Price · USD
2.410
+0.060 (2.55%)
May 1, 2024, 4:00 PM EDT - Market closed

Stereotaxis Revenue

In the year 2023, Stereotaxis had annual revenue of $26.77M, a decrease of -4.89%. Revenue in the quarter ending December 31, 2023 was $4.57M, a -37.47% decrease year-over-year.

Revenue (ttm)
$26.77M
Revenue Growth
-4.89%
P/S Ratio
7.39
Revenue / Employee
$219,434
Employees
122
Market Cap
197.93M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202326.77M-1.38M-4.89%
Dec 31, 202228.15M-6.87M-19.63%
Dec 31, 202135.02M8.39M31.51%
Dec 31, 202026.63M-2.27M-7.86%
Dec 31, 201928.90M-444.07K-1.51%
Dec 31, 201829.35M-1.80M-5.77%
Dec 31, 201731.14M-1.02M-3.17%
Dec 31, 201632.16M-5.51M-14.63%
Dec 31, 201537.67M2.66M7.61%
Dec 31, 201435.01M-3.02M-7.94%
Dec 31, 201338.03M-8.53M-18.32%
Dec 31, 201246.56M4.58M10.90%
Dec 31, 201141.99M-12.06M-22.32%
Dec 31, 201054.05M2.90M5.67%
Dec 31, 200951.15M10.78M26.72%
Dec 31, 200840.37M1.07M2.71%
Dec 31, 200739.30M12.11M44.52%
Dec 31, 200627.19M12.17M80.96%
Dec 31, 200515.03M-3.79M-20.14%
Dec 31, 200418.82M13.80M275.22%
Dec 31, 20035.01M5.00M26,433.74%
Dec 31, 200218.90K--
Dec 31, 20010--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Lifecore Biomedical 103.27M
Akoya Biosciences 96.63M
Alimera Sciences 80.75M
Century Therapeutics 2.24M
Cardiff Oncology 488.00K
Revenue Rankings